| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в лютому 1989 (uk)
- im Februar 1989 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en febreru de 1989 (ast)
- artikull shkencor i botuar më 01 shkurt 1989 (sq)
- scientific article published on 01 February 1989 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - S Matsui
- T Oka
- N Yoshimura
- T Hamashima
|
| rdfs:label
| - Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (en)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (nl)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (sq)
|
| skos:prefLabel
| - Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (en)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (nl)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (sq)
|
| name
| - Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (en)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (nl)
- Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (sq)
|
| title
| |
| title
| - Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1097/00007890-198902000-00034
|
| is about
of | |
| is cites work
of | - FK506 augments activation-induced programmed cell death of T lymphocytes in vivo
- Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy
- A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase
- Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus
- Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms
- The influence of FK-506 on the thymus: an immunophenotypic and structural analysis
- The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies
- FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes
- The Influence of FK-506 and Low-Concentration Ciclosporin on Human Lymphocyte Activation Antigen Expression and Blastogenesis: a Flow Cytometric Analysis
- Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation
- [Systemic immunosuppressives after penetrating keratoplasty]
- Development of a robust method for establishing B cell lines using Epstein-Barr Virus.
- Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production
- Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs
- Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate
- Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein
- Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal
- FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes
- Antigen presentation and HLA-DR expression by FK-506-treated human monocytes
- The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation
- Current status of renal transplantation
- Effects of a novel immunosuppressive agent, FK506, on human B cell activation
- Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium
- Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion
- Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506
- Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate
- Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation
- Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells
- Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig‐to‐rat model
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)